Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Hargreaves Services starts to unlock asset value

Director deals: Franchise Brands attracts buying at bargain price

Aquis weekly movers: ProBiotix Health sales grow

AIM weekly movers: Good news about Redmoor for Strategic Minerals

AIM movers: Steppe Cement increases sales and Mosman Oil and Gas raises cash

AIM movers: EnSilica hit by delays and ex-dividends

AIM movers: ActiveOps recurring revenues accelerate and signs of recovery at Sanderson Design

AIM movers: Another upgrade for Gear4Music and Eco Buildings new Sudan subsidiary

AIM movers: Redmoor drilling success for Strategic Minerals and Helium One Global terminates investment agreement

S&U set for recovery

AIM weekly movers: WH Ireland considers options

Aquis weekly movers: All Things Considered buys US merchandise business

AIM movers: Genedrive stake increase and WH Ireland continues to fall

AIM movers: Petro Matad test flows impress and ex-dividends

AIM movers: WH Ireland could lose general meeting vote and Angle refines strategy

AIM movers: Reabold Resources selling LNEnergy stake and First Development Resources drilling difficulties

AIM movers: HSS hire transformation and Quartix upgrade

AIM weekly movers: Hydrogen storage prospects improve for UK Oil and Gas

Aquis weekly movers: Richmond Hill returns from suspension after prospectus launched

AIM movers: Polar Capital upgraded

AIM movers: Boku is AIM company of the year and ex-dividends

AIM movers: UK Oil and Gas collaboration with National Gas Transmission and Litigation Capital Management loss

AIM movers: SEEEN grows revenues and Billington hit by delays

AIM movers: EnergyPathways confirms MESH recommendation and Spectra Systems downgrade

Directors deals: Finseta buying after poor interims

AIM movers: EnergyPathways’ MESH nears approval

Aquis weekly movers: All Things Considered increases revenues

AIM movers: Brighter outlook for Gemfields and EnergyPathways share price recovers

AIM movers: Arecor Therapeutics collaboration and ex-dividends

AIM movers: Nigel Wray doubles stake in Sosandar and Fiske under FCA restrictions

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020